OPINIONHEALTHCARE PRICE REGULATION
Cap the Margin, Not the Medicine: Why India Should Limit Trade Margins on Every Drug and Consumable
The Indian Express published the piece after Maharashtra FDA Commissioner Tukaram Mundhe released examples of large markups on medical items sold in hospitals and issued directions that hospitals cannot force admitted patients to buy only from in-house pharmacies. The Supreme Court is separately hearing a PIL on cancer drug prices, in which it criticised the gap between the price to retailers and the MRP.
UPSC Relevance9/10
Time to Read3 min read
Total Views39,554
Read Analysis